Your browser doesn't support javascript.
loading
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.
Carvajal, Richard D; Sosman, Jeffrey A; Quevedo, Jorge Fernando; Milhem, Mohammed M; Joshua, Anthony M; Kudchadkar, Ragini R; Linette, Gerald P; Gajewski, Thomas F; Lutzky, Jose; Lawson, David H; Lao, Christopher D; Flynn, Patrick J; Albertini, Mark R; Sato, Takami; Lewis, Karl; Doyle, Austin; Ancell, Kristin; Panageas, Katherine S; Bluth, Mark; Hedvat, Cyrus; Erinjeri, Joseph; Ambrosini, Grazia; Marr, Brian; Abramson, David H; Dickson, Mark Andrew; Wolchok, Jedd D; Chapman, Paul B; Schwartz, Gary K.
Afiliación
  • Carvajal RD; Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York.
  • Sosman JA; Vanderbilt University Medical Center, Department of Hematology-Oncology, Nashville, Tennessee.
  • Quevedo JF; Mayo Clinic, Rochester, Minnesota.
  • Milhem MM; University of Iowa Hospital and Clinics, Iowa City.
  • Joshua AM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Kudchadkar RR; H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Linette GP; Washington University, St Louis, Missouri.
  • Gajewski TF; University of Chicago, Chicago, Illinois.
  • Lutzky J; Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida.
  • Lawson DH; Winship Cancer Institute of Emory University, Atlanta, Georgia.
  • Lao CD; University of Michigan, Ann Arbor.
  • Flynn PJ; Metro Minnesota Community Clinical Oncology Program, St Louis Park.
  • Albertini MR; University of Wisconsin, Madison.
  • Sato T; Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Lewis K; University of Colorado, Aurora.
  • Doyle A; Investigational Drug Branch, National Cancer Institute, Rockville, Maryland.
  • Ancell K; Vanderbilt University Medical Center, Department of Hematology-Oncology, Nashville, Tennessee.
  • Panageas KS; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Bluth M; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Hedvat C; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Erinjeri J; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Ambrosini G; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Marr B; Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Abramson DH; Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York.
  • Dickson MA; Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York.
  • Wolchok JD; Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York.
  • Chapman PB; Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York.
  • Schwartz GK; Memorial Sloan-Kettering Cancer Center, New York, New York2Weill Medical College of Cornell University, New York, New York.
JAMA ; 311(23): 2397-405, 2014 Jun 18.
Article en En | MEDLINE | ID: mdl-24938562
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Bencimidazoles / Antineoplásicos Alquilantes / Dacarbazina / Melanoma Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Bencimidazoles / Antineoplásicos Alquilantes / Dacarbazina / Melanoma Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2014 Tipo del documento: Article